引用次数
引用: 10,515
H-指数: 55
I10-指数 : 224
出版物: 807
[The effects of nicotine on the circulation and metabolism after cigarette smoking with reference to the plasma levels of nicotine and COHb (author's transl)]
Hengen N , Walter E , Augustin J , Weber E
Münchener medizinische Wochenschrift 25 -32
1980
Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin.
Harenberg J , Kübler W , Dempfle Ce , Stehle G
Seminars in Thrombosis and Hemostasis 19 116 -121
41
1993
Altered pharmacokinetic properties of a lipophilically derivatized low-molecular-weight heparin in rats.
Harenberg J , Peschke P , Wunder A , Dempfle Ce
Journal of Laboratory and Clinical Medicine 122 ( 6) 728 -738
5
1993
Clinical and metabolic effects of gestodene and levonorgestrel.
Runnebaum B , Kohlmeier M , Weicker H , Harenberg J
International Journal of Fertility 29 -44
22
1987
Pharmacologic profile of low molecular weight heparin
Harenberg J , Schettler G , Würzner B , Zimmermann R
Medizinische Klinik (Munich, Germany : 1983). Supplement 3 4 -8
1986
Long term anticoagulation with low molecular weight heparin in outpatients with side effects on oral anticoagulants.
Harenberg J , Leber G , Kübler W , Dempfle Ce
Nouvelle revue française d'hématologie 31 ( 5) 363 -369
22
1989
Preferential binding of heparin to granulocytes of various species.
Harenberg J , Heene Dl , Piazolo L , Malsch R
American Journal of Veterinary Research 57 ( 7) 1016 -1020
2
1996
[Anticoagulation with low molecular-weight heparin in patients with prosthetic heart valve replacements].
Dietz R , Leber G , Schwarz F , Kübler W
Zeitschrift Fur Kardiologie 76 ( 5) 284 -288
7
1987
Dosage of urokinase in venous thrombosis of the lower extremities
Harenberg J , Zimmermann R
Deutsche Medizinische Wochenschrift 105 ( 35) 1228
2
1980
Subclavian vein thromboses as a complication of peripheral and central venous catheters
Mörl H , Harenberg J , Zimmermann R
Deutsche Medizinische Wochenschrift 109 ( 34) 1305
1
1984
Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
Harenberg J
Journal Des Maladies Vasculaires 68 -70
6
1987
Anti-factor Xa determination in blood: a new method for controlling heparin therapy.
Harenberg J , Heene Dl , Dempfle Ce , Stehle G
Seminars in Thrombosis and Hemostasis 19 79 -85
3
1993
[Effect of furosemide on human blood coagulation, fibrinolysis and thrombocyte function].
Weber E , Spohr U , Walter E , Zimmermann R
Verhandlungen der Deutschen Gesellschaft für Innere Medizin ( 84) 1375
1978
[Anticoagulation in thrombolytic therapy: importance and future perspectives].
Heene Dl , Harenberg J
Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete 48 283
1993
Treatment of manifest thrombosis
Harenberg J , Heene Dl
Chirurg 63 ( 4) 276
1992
[Prescription figures and adverse effects of digitalis glycosides. A 2-year comparison of inpatients at a university hospital].
Harenberg J , Staiger C , Schaefer Do , Spohr U
Münchener medizinische Wochenschrift 125 ( 51) 1199
1983
Anticoagulation in patients with heart valve replacement in pregnancy
Harenberg J
Zeitschrift Fur Kardiologie 63
3
1998
The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects.
Harenberg J , Stehle G , von Hodenberg E , Dempfle Ce
Folia haematologica (Germany) 116 ( 6) 967
5
1989
[Prevention of thromboembolism with low-molecular-weight heparin in ambulatory surgery and unoperated surgical and orthopedic patients].
Misselwitz F , Harenberg J , Piazolo L
Zentralblatt Fur Chirurgie 123 ( 11) 1284 -1287
10
1998
Ximelagatran for treatment of venous thromboembolism
Harenberg J , Fenyvesi T , Jörg I
Hamostaseologie 22 ( 3) 25
2002